Showing 1 - 10 of 35
Persistent link: https://www.econbiz.de/10014232642
We analyse how a patent-holding pharmaceutical firm may strategically use advertising of existing drugs to affect R&D investments in new (differentiated) drugs, and thereby affect the probability distribution of future market structures in the industry. Within a fairly general model framework,...
Persistent link: https://www.econbiz.de/10003771873
Persistent link: https://www.econbiz.de/10003278390
Persistent link: https://www.econbiz.de/10003903146
Persistent link: https://www.econbiz.de/10003459149
Persistent link: https://www.econbiz.de/10003604229
Persistent link: https://www.econbiz.de/10003379831
We consider a therapeutic market with potentially three pharmaceutical firms. Two of the firms offer horizontally differentiated brand-name drugs. One of the brand-name drugs is a new treatment under patent protection that will be introduced if the profits are sufficient to cover the entry...
Persistent link: https://www.econbiz.de/10003393611
Persistent link: https://www.econbiz.de/10008655517
Persistent link: https://www.econbiz.de/10010515278